New two-year data for Roche’s Vabysmo and Susvimo reinforce potential to maintain vision with fewer treatments for people with two leading causes of vision loss
In the YOSEMITE and RHINE studies in diabetic macular edema, at least 60% of eligible…
News
Nykode Therapeutics announces completion of patient enrollment in its Phase 2 trial of VB10.16 in combination with atezolizumab for the treatment of advanced cervical cancer
Nykode Therapeutics has reached the enrollment target of 50 patients in its VB C-02 trial…
Genocea to Present at the 11th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical…
Facedrive Provides Update on Facedrive Foods’ Revenue and Expenses
TORONTO–(BUSINESS WIRE)–#FacedriveScarborough–Facedrive Inc. (“Facedrive” or the “Company”) (TSXV:FD), (OTC:FDVRF), a Canadian “people-and-planet first” tech ecosystem…
Twist Bioscience Announces Pricing of an Upsized $250 Million Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed…
IN8bio to present at Bio CEO & Investor Conference and Next Generation CAR-TCR Summit
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta…
OpGen Announces Publication of Results from the Acuitas AMR Gene Panel Multicenter Clinical Trial in the Journal of Clinical Microbiology
Publication demonstrates FDA cleared Acuitas AMR Gene Panel detects and differentiates a broad range of…
Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, Feb. 10, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Cellectis Appoints Bing Wang, PhD, MBA as Chief Financial Officer
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
VistaGen Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
Advancing late-stage PH94B clinical program, including: Progress towards topline data readouts for PALISADE-1 and PALISADE-2…
ObsEva Enters into Licensing Agreement with Theramex for the Commercialization of Linzagolix
– Partnership leverages Theramex’s leading women’s health capabilities and commercial infrastructure to support the commercialization…
Telix and SHINE partner for Lutetium-177 Supply
MELBOURNE, Australia and INDIANAPOLIS, Feb. 10, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX,…
FDA Denies Citizen Petitions Filed on Behalf of Short Selling Clients
AUSTIN, Texas, Feb. 10, 2022 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage…
Celldex to Present at the 11th Annual SVB Leerink Global Healthcare Conference
HAMPTON, N.J., Feb. 10, 2022 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that…
GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
– Discussions underway between the University of Newcastle and GBS to oversee the high-tech manufacturing…
Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022
LungFit® PH premarket approval (PMA) submission under active review by U.S. FDA; approval and commercial…
Codexis to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24
REDWOOD CITY, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Ascendis Pharma A/S to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
COPENHAGEN, Denmark, Feb. 10, 2022 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
DICE Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE),…